HEPATITIS C TREATMENT CONTINUATION RATES IN TREATMENT-NAIVE GENOTYPE 1 PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM

被引：0
|
作者：
Mussolino, F. [1 ]
Vaz, P. [1 ]
Morais, A. D. [2 ]
Pereira, M. L. [2 ]
机构：
[1] NEW BD Business Developers, Sao Paulo, Brazil
[2] Janssen Cilag Farmaceut, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.273
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A281 / A281
页数：1
相关论文
共 50 条
  • [41] COST PER CURE OF TELAPREVIR AND BOCEPREVIR IN TREATMENT-NAIVE GENOTYPE 1 HEPATITIS C PATIENTS WITH F2 FIBROSIS IN BRAZIL
    Morais, A. D.
    Pereira, M. L.
    VALUE IN HEALTH, 2013, 16 (07) : A352 - A352
  • [42] Cost-effectiveness of daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b treatment-naive patients in China
    Lu, Yun
    Jin, Xiuze
    Duan, Cheng-a-xin
    Chang, Feng
    PLOS ONE, 2018, 13 (04):
  • [43] Cost-effectiveness analysis of simeprevir in combination with peginterferon and ribavirin for treatment-naive chronic hepatitis C genotype 1 patients in Japan
    Kuwabara, Hiroyo
    Westerhout, Kirsten
    Treur, Maarten
    Cerri, Karin
    Mahlich, Joerg
    Yatsuhashi, Hiroshi
    JOURNAL OF MEDICAL ECONOMICS, 2015, 18 (07) : 502 - 511
  • [44] A personalized approach to optimize hepatitis B treatment in treatment-naive patients
    Marcellin, Patrick
    Liang, Jake
    ANTIVIRAL THERAPY, 2010, 15 : 53 - 59
  • [45] Diversity of hepatitis C virus envelope associated with fibrosis in treatment-naive patients
    Banica, Leontina
    Paraschiv, Simona
    Neaga, Emil
    Gheorghita, Valeriu
    Batan, Ionelia
    Vlaicu, Ovidiu
    Popescu, Costin Ioan
    Otelea, Dan
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [46] Sixteen-year Prognosis of Treatment-naive Patients with Hepatitis C Infection
    Karacaer, Zehra
    Tosun, Selma
    Batirel, Ayse
    Acar, Ali
    Celik, Neslihan
    Uguz, Mustafa
    Yavuz, Songul
    Yenilmez, Ercan
    Dogan, Mustafa
    Yalcin, Tugba Yanik
    Sezer, Busra Ergut
    Oztoprak, Nefise
    Aydin, Ozlem
    Yildiz, Ilknur Esen
    Kostakoglu, Ugur
    Ergen, Pinar
    Cetinkaya, Riza Aytac
    Durmus, Gul
    Gozukucuk, Ramazan
    Coskuner, Seher Ayten
    Artuk, Cumhur
    Goktas, Emine Firat
    Guven, Emre
    Bekcibasi, Muhammed
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2019, 25 (01): : 19 - 24
  • [47] A Cost-Effectiveness Analysis of Shortened Direct-Acting Antiviral Treatment in Genotype 1 Noncirrhotic Treatment-Naive Patients With Chronic Hepatitis C Virus
    Fawsitt, Christopher G.
    Vickerman, Peter
    Cooke, Graham
    Welton, Nicky J.
    Barnes, Eleanor
    Ball, Jonathan
    Brainard, Diana
    Burgess, Gary
    Cooke, Graham
    Dillon, John
    Foster, Graham
    Gore, Charles
    Guha, Neil
    Halford, Rachel
    Whitby, Kevin
    Holmes, Chris
    Howe, Anita
    Hudson, Emma
    Hutchinson, Sharon
    Irving, William
    Khakoo, Salim
    Klenerman, Paul
    Martin, Natasha
    Massetto, Benedetta
    Mbisa, Tamyo
    McHutchison, John
    McKeating, Jane
    McLauchlan, John
    Miners, Alec
    Murray, Andrea
    Shaw, Peter
    Simmonds, Peter
    Spencer, Chris
    Thomson, Emma
    Vickerman, Peter
    Zitzmann, Nicole
    VALUE IN HEALTH, 2019, 22 (06) : 693 - 703
  • [48] Autonomic impairment in treatment-naive patients with chronic hepatitis B and C infections
    Huang, Chih-Cheng
    Wu, Keng-Liang
    Liu, Jia-Shou
    Chang, Yung-Yee
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2022, 238
  • [49] Efficacy and safety of ledipasvir/sofosbuvir in treatment-naive and-experienced patients with hepatitis C virus genotype 6 infection
    Thong, Vo D.
    HEPATOLOGY, 2017, 66 : 604A - 605A
  • [50] MANAGEMENT OF CHRONIC HEPATITIS C (CHC) GENOTYPE 1 TREATMENT-NAIVE PATIENTS IN AN ERA OF RISING OPPORTUNITIES AND COSTS - A COST-EFFECTIVENESS ANALYSIS OF TREATMENT OPTIONS
    Cortesi, P. A.
    Ciaccio, A.
    Rota, M.
    De Salvia, S.
    Vinci, M.
    Belli, L. S.
    Lim, J. K.
    Mantovani, L. G.
    Strazzabosco, M.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S493 - S493
12345